In this context, an in vitro study, performed to understand the age-related decline of primary CD8+ T cell response in COVID-19 [52], showed that immune-aging, by affecting the percentage of circulating naïve CD8+ T cells, weakened the primary response in terms of magnitude, intensity and number of recognized epitopes and thus increasing disease severity [52]. Here, CD8A is linked to COVID-19.